Bicycle Therapeutics (BCYC) Shares Outstanding (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Shares Outstanding (Entity) data on file, last reported at $69.8 million in Q2 2026.

• Quarterly Shares Outstanding (Entity) rose 0.81% year-over-year to $69.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $69.8 million (up 0.81% YoY) and the FY2025 annual result came in at $69.4 million, changed 0.44% from the prior year.
• Shares Outstanding (Entity) steadied at $69.8 million in Q2 2026, from $69.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $69.8 million in Q2 2026 to a low of $29.6 million in Q1 2022.
• A 5-year average of $50.8 million and a median of $47.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) surged 69.99% — and 2025, when it increased 0.42%.
• Tracing BCYC's Shares Outstanding (Entity) over 5 years: stood at $29.9 million in 2022, then surged by 42.04% to $42.4 million in 2023, then soared by 62.76% to $69.1 million in 2024, then grew by 0.44% to $69.4 million in 2025, then climbed by 0.64% to $69.8 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $69.8 million (Q2 2026), $69.7 million (Q1 2026), and $69.4 million (Q4 2025), per Business Quant data.